Find uplifting stories about heroes, innovations, and solutions
5322 results for "vaccine manufacturing"
African nations are building their own vaccine production systems after being left at the back of the line during global health crises. A $1.2 billion initiative and new manufacturing hubs are turning dependence into self-reliance.
Africa is taking bold steps to produce its own medicines and vaccines, aiming to manufacture 60% locally by 2040 while fixing health financing gaps that force families into poverty. The continent's health leaders are tackling inefficiencies that waste millions and leave people paying for healthcare out of pocket.
Egypt is teaming up with pharmaceutical giant Pfizer to manufacture vaccines and medicines right at home, reducing dependence on imports and strengthening healthcare for millions. The partnership could transform how the nation delivers critical treatments to its people.
Scientists at Harvard have created a new DNA origami vaccine that works as well as mRNA shots but doesn't need freezers and is simpler to manufacture. The breakthrough could make life-saving vaccines accessible to millions more people worldwide.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
Egypt's health ministry is teaming up with pharmaceutical giant Pfizer to expand cancer treatment, improve care for hemophilia patients, and manufacture vaccines locally. The partnership could transform healthcare access for millions across the nation.
African researchers are racing to develop the continent's first chikungunya vaccine designed specifically for children and local populations. Rwanda is leading a four-year, $17 million partnership across four African nations to test and eventually manufacture the life-saving vaccine.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
Egypt is teaming up with pharmaceutical giant Pfizer to manufacture vaccines and medicines domestically, moving the country closer to healthcare independence. The partnership aims to reduce reliance on imports while expanding cancer care and training programs.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
Showing 20 of 5322